Company profile
Clinical Laserthermia Systems company profile
Clinical Laserthermia Systems (CLS) develops and markets the TRANBERG®|Thermal Therapy System, as well as disposable materials and methods, for heat-induced immunotherapy enabling safe and gentle treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for CLS’ own immunostimulating therapy, imILT®. The company is headquartered in Lund, Sweden, with subsidiaries in Berlin, Germany and in Boston, USA. CLS is listed on Nasdaq First North under the stock symbol CLS B.
Business identity
- Website
- https://clinicallaser.se
- Contact email
- [email protected]
- Phone number
- 046-15 21 00
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2006-01-01, Year
Headquarters
- Headquarters
- Byumba, Northern Province, Rwanda
- Postal code
- 223 81
- Country code
- RW
- Continent
- Africa